Cipla
Satyen Manikani currently holds the position of Head - Product Portfolio and Strategy at Cipla since February 2022. Prior to this role, Satyen served as Senior Vice President at USV PRIVATE LIMITED from May 2021 to February 2022, and as Assistant Vice President of Strategy, In-Licensing & Business Development at Alkem Labs from October 2010 to May 2019. Satyen's earlier experience includes a role as Senior Manager of Strategic Marketing at Ranbaxy from September 2006 to October 2010, and Deputy General Manager of Marketing at Elder Pharma from 2004 to August 2006. Satyen's expertise includes the identification of therapy gaps in product portfolios across various divisions, strategizing new market entries, and overseeing product launches through in-licensing and development collaborations. Satyen holds a Bachelor of Pharmacy degree from NDMVP Samaj's College of Pharmacy Nashik and Savitribai Phule Pune University, as well as an SSC degree from Gurukul High School Ghatkopar.
Previous companies
This person is not in any teams
This person is not in any offices
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.